If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Atsushi Nonami is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 1219 Citations
  • 20 h-Index
  • 31 Article
  • 2 Letter
  • 2 Review article

Cell-based screen identifies a new potent and highly selective CK2 inhibitor for modulation of circadian rhythms and cancer cell growth

Oshima, T., Niwa, Y., Kuwata, K., Srivastava, A., Hyoda, T., Tsuchiya, Y., Kumagai, M., Tsuyuguchi, M., Tamaru, T., Sugiyama, A., Ono, N., Zolboot, N., Aikawa, Y., Oishi, S., Nonami, A., Arai, F., Hagihara, S., Yamaguchi, J., Tama, F., Kunisaki, Y. & 6 others, Yagita, K., Ikeda, M., Kinoshita, T., Kay, S. A., Itami, K. & Hirota, T., Jan 23 2019, In : Science Advances. 5, 1, eaau9060.

Research output: Contribution to journalArticle

Open Access
  • 17 Citations (Scopus)

    Inhibition of USP10 induces degradation of oncogenic FLT3

    Weisberg, E. L., Schauer, N. J., Yang, J., Lamberto, I., Doherty, L., Bhatt, S., Nonami, A., Meng, C., Letai, A., Wright, R., Tiv, H., Gokhale, P. C., Ritorto, M. S., De Cesare, V., Trost, M., Christodoulou, A., Christie, A., Weinstock, D. M., Adamia, S., Stone, R. & 8 others, Chauhan, D., Anderson, K. C., Seo, H. S., Dhe-Paganon, S., Sattler, M., Gray, N. S., Griffin, J. D. & Buhrlage, S. J., Dec 1 2017, In : Nature Chemical Biology. 13, 12, p. 1207-1215 9 p.

    Research output: Contribution to journalArticle

  • 34 Citations (Scopus)

    Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors

    Tan, L., Rao, S., Mowafy, S., Du, G., Gray, N. S., Gurbani, D., Weisberg, E. L., Jones, D. S., Singer, W. D., Bernard, F. M., Jenney, A., Nonami, A., Griffin, J. D., Lauffenburger, D. A., Westover, K. D. & Sorger, P. K., 2017, In : Bioorganic and Medicinal Chemistry. 25, 4, p. 1320-1328 9 p.

    Research output: Contribution to journalArticle

  • 9 Citations (Scopus)

    Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia

    Wu, H., Hu, C., Wang, A., Weisberg, E. L., Chen, Y., Yun, C. H., Wang, W., Liu, Y., Liu, X., Tian, B., Wang, J., Zhao, Z., Liang, Y., Li, B., Wang, L., Wang, B., Chen, C., Buhrlage, S. J., Qi, Z., Zou, F. & 14 others, Nonami, A., Li, Y., Fernandes, S. M., Adamia, S., Stone, R. M., Galinsky, I. A., Wang, X., Yang, G., Griffin, J. D., Brown, J. R., Eck, M. J., Liu, J., Gray, N. S. & Liu, Q., Jan 1 2016, In : Leukemia. 30, 1, p. 173-181 9 p.

    Research output: Contribution to journalArticle

  • 21 Citations (Scopus)

    Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML

    Wu, H., Hu, C., Wang, A., Weisberg, E. L., Wang, W., Chen, C., Zhao, Z., Yu, K., Liu, J., Wu, J., Nonami, A., Wang, L., Wang, B., Stone, R. M., Liu, S., Griffin, J. D., Liu, J. & Liu, Q., Mar 1 2016, In : Leukemia. 30, 3, p. 754-757 4 p.

    Research output: Contribution to journalLetter

    17 Citations (Scopus)